Grifols GRFS
NASDAQ GRFS
$7.50 -0.04 (-0.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Operating Leases (2015 - 2025)

Updated

Grifols (GRFS) recorded Operating Leases of $1.13 billion in the quarter ended Dec 31, 2025, up 3.0% from $1.1 billion a year earlier.

Analysis

Grifols (GRFS) Operating Leases (2015 - 2025) Analysis & Trends

As of Dec 31, 2025, Grifols reported Operating Leases of $1.09 billion, unchanged from the prior year.

  • Annual Operating Leases has a five-year compound annual growth rate of 6.8% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Operating Leases came in at $1.1 billion in the year ended Dec 31, 2024 (+1.4%), $1.08 billion in the year ended Dec 31, 2023 (+15.8%), $933.11 million in the year ended Dec 31, 2022 (-1.1%) and $943.96 million in the year ended Dec 31, 2021 (+19.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Grifols 5.11 Bn 1.45 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.14 Bn
Dec 31, 2024 1.07 Bn
Dec 31, 2023 1.11 Bn
Dec 31, 2022 975.02 Mn
Dec 31, 2021 934.49 Mn
Dec 31, 2020 849.75 Mn
Dec 31, 2019 780.00 Mn
Mar 31, 2016 853.41 Mn
Dec 31, 2015 854.40 Mn
API Access

Grifols Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=GRFS&period=max&api_key=YOUR_API_KEY